84 related articles for article (PubMed ID: 7974336)
21. Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction.
Saigo M; Abe S; Ogawa M; Biro S; Minagoe S; Maruyama I; Toda H; Kiyonaga K; Atsuchi Y; Tahara M; Mawatari K; Tei C
Thromb Res; 2000 Oct; 100(1):9-17. PubMed ID: 11053611
[TBL] [Abstract][Full Text] [Related]
22. Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study.
Brodin E; Børvik T; Sandset PM; Bønaa KH; Nordøy A; Hansen JB
Thromb Haemost; 2004 Jul; 92(1):178-84. PubMed ID: 15213859
[TBL] [Abstract][Full Text] [Related]
23. [Increased fibrinogen and factor VII activity levels in patients after myocardial infarction].
Mamont B; Sawicka B
Kardiol Pol; 1992 Nov; 37(11):283-6. PubMed ID: 1287288
[TBL] [Abstract][Full Text] [Related]
24. Response of plasma tissue factor pathway inhibitor to diet-induced hypercholesterolemia in crab-eating monkeys.
Abumiya T; Nakamura S; Takenaka A; Takenaka O; Yoshikuni Y; Miyamoto S; Kimura T; Enjyoji K; Kato H
Arterioscler Thromb; 1994 Mar; 14(3):483-8. PubMed ID: 8123656
[TBL] [Abstract][Full Text] [Related]
25. Association between coagulation factors VII and X with triglyceride rich lipoproteins.
de Sousa JC; Soria C; Ayrault-Jarrier M; Pastier D; Bruckert E; Amiral J; Bereziat G; Caen JP
J Clin Pathol; 1988 Sep; 41(9):940-4. PubMed ID: 3056986
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia.
Kokawa T; Abumiya T; Kimura T; Harada-Shiba M; Koh H; Tsushima M; Yamamoto A; Kato H
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):504-10. PubMed ID: 7749862
[TBL] [Abstract][Full Text] [Related]
27. Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.
Hansen JB; Huseby NE; Sandset PM; Svensson B; Lyngmo V; Nordøy A
Arterioscler Thromb; 1994 Feb; 14(2):223-9. PubMed ID: 8305412
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction.
Roldán V; Marín F; Fernández P; Luján J; Martínez JG; Pineda J; Marco P; Sogorb F
Int J Cardiol; 2001 Apr; 78(2):115-9. PubMed ID: 11334654
[TBL] [Abstract][Full Text] [Related]
29. TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complications.
Novo G; Caplice N; Tantillo R; Bonura F; Simari R; Novo S
Int Angiol; 2005 Dec; 24(4):366-71. PubMed ID: 16355095
[TBL] [Abstract][Full Text] [Related]
30. Changes in the lipoprotein pattern during two years following myocardial infarction.
Ritland S; Enger SC
Acta Med Scand; 1972 May; 191(5):447-50. PubMed ID: 4337999
[No Abstract] [Full Text] [Related]
31. Plasma lipoproteins enhance tissue factor-independent factor VII activation.
Kjalke M; Silveira A; Hamsten A; Hedner U; Ezban M
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1835-41. PubMed ID: 10894826
[TBL] [Abstract][Full Text] [Related]
32. [Myocardial infarct. Lipoprotein lipase in the myocardium and the infarct].
Gaddi A; Descovich GC
Minerva Cardioangiol; 1980 Jun; 28(6):375-82. PubMed ID: 7242924
[No Abstract] [Full Text] [Related]
33. Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy.
Yokoyama H; Myrup B; Rossing P; Ostergaard PB
Diabetes Care; 1996 May; 19(5):441-5. PubMed ID: 8732706
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect.
Chouhan VD; Comerota AJ; Sun L; Harada R; Gaughan JP; Rao AK
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2812-7. PubMed ID: 10559031
[TBL] [Abstract][Full Text] [Related]
35. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation.
Yamamuro M; Wada H; Kumeda K; Inoue A; Tsuji I; Nakasaki T; Shimura M; Hiyoyama K; Gabazza EC; Nishikawa M; Deguchi K; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):491-7. PubMed ID: 9818999
[TBL] [Abstract][Full Text] [Related]
36. Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state.
Ertenli I; Kiraz S; Celik IC; Haznedaroglu C; Erman M; Calgüneri M; Kirazli S
Ann Rheum Dis; 2001 Dec; 60(12):1149-51. PubMed ID: 11709459
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?
Erman M; Abali H; Oran B; Haznedaroglu IC; Canpinar H; Kirazli S; Celik I
Ann Oncol; 2004 Nov; 15(11):1622-6. PubMed ID: 15520062
[TBL] [Abstract][Full Text] [Related]
38. Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI).
Hansen JB; Olsen JO; Osterud B
Thromb Haemost; 1990 Aug; 64(1):124-6. PubMed ID: 2274917
[TBL] [Abstract][Full Text] [Related]
39. The increase with age of the components of the tissue factor coagulation pathway is gender-dependent.
Ariëns RA; Coppola R; Potenza I; Mannucci PM
Blood Coagul Fibrinolysis; 1995 Jul; 6(5):433-7. PubMed ID: 8589210
[TBL] [Abstract][Full Text] [Related]
40. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.
Mitropoulos KA; Miller GJ; Reeves BE; Wilkes HC; Cruickshank JK
Atherosclerosis; 1989 Apr; 76(2-3):203-8. PubMed ID: 2730717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
